Vaclav Ranc | Cancer Cell Biology | Best Researcher Award

Assoc. Prof. Dr. Vaclav Ranc | Cancer Cell Biology | Best Researcher Award

Assoc. Prof. Dr. Vaclav Ranc | Palacký University in Olomouc | Czech Republic

Dr. Václav Ranc is a distinguished analytical chemist and data analyst with over 15 years of experience in academia and applied research. Based in the Czech Republic, he leads a research group at Palacký University Olomouc, specializing in nanotechnology, plasmonic and electronic nanosensors, and advanced analytical techniques. He holds a Ph.D. in Analytical Chemistry and a Habilitation in Physical Chemistry. Dr. Ranc has published over 80 peer-reviewed scientific articles and holds several international patents. He has secured and managed significant EU funding, including Horizon Europe and MSCA projects, showcasing his excellence in both research and project leadership. His expertise spans Raman spectroscopy, mass spectrometry, and LC/GC methods, coupled with data analysis in Python, Matlab, and R. He is a regular presenter at international conferences and a recognized innovator in the fields of biosensing and nanomaterials.

Publication Profiles: 

Google Scholar
Orcid
Scopus

Education:

Dr. Václav Ranc earned his MSc. in Analytical Chemistry from Palacký University Olomouc (UPOL) in 2005, where he focused on the discrimination of enantiomers using mass spectrometry techniques such as LC-MS and CE-MS. He continued at UPOL to complete his Ph.D. in Analytical Chemistry, specializing in chiral analysis with HPLC-MS and GC-MS. His academic trajectory culminated in a Habilitation in Physical Chemistry, reflecting his advancements in Raman microscopy, SERS, and mass spectrometry. Dr. Ranc’s education is deeply rooted in analytical and physical chemistry, with a significant emphasis on developing and applying sophisticated separation and detection techniques for complex biological and clinical samples. His academic background is further enriched by international research experiences in Sweden and Switzerland, where he worked on electroanalytical techniques and nanoLC-MS applications for neurotransmitter analysis.

Experience:

Dr. Václav Ranc currently serves as the Head of a Research Group at Palacký University Olomouc, managing a 20-member team focused on cutting-edge nanomaterials and analytical chemistry. He has led the group’s scientific, financial, and personnel management, improving research output by 30%. Previously, he worked as a Research Assistant in Switzerland and at Palacký University, where he developed analytical techniques for clinical and neurological studies using mass spectrometry. His earlier roles include assisting in electrochemical method development at Lund University and clinical toxicology at Faculty Hospital Olomouc. His leadership extends to managing multimillion-CZK budgets and delivering impactful results in EU-funded research projects. Throughout his career, he has seamlessly combined academic excellence with innovation, leading to patented technologies and industrial prototypes, while mentoring young researchers and collaborating with international scientific networks.

Honors & Awards:

Dr. Václav Ranc has received several national and international honors for his scientific excellence. Notable among them is the Golden Medal at the International Invent Arena for the innovative KeyLock authentication system. He also earned the Bronze Prize from MERCK’s Young Analytical Chemists Competition and was a Finalist for the prestigious Shimadzu Prize for Young Analytical Chemists. His awards reflect consistent recognition for his groundbreaking work in analytical chemistry and applied nanotechnology. These accolades underscore his ability to translate complex research into practical applications, particularly in biosensing, authentication systems, and advanced materials. Dr. Ranc’s career is marked by impactful innovations that bridge academic research with industry needs, affirming his role as a thought leader in his field. His awarded projects and patents have contributed significantly to medical diagnostics, material sciences, and anti-counterfeiting technologies.

Research Focus:

Dr. Ranc’s research focuses on analytical chemistry, nanotechnology, and biosensing. He specializes in Raman spectroscopy (including SERS), LC/GC-MS, and the development of plasmonic and electronic nanosensors. His work bridges basic science and applied innovation, emphasizing the synthesis of nanoparticles, development of authenticity verification systems, and detection of biomarkers in clinical diagnostics. His contributions to surface-enhanced Raman spectroscopy have led to the development of patented methods and tools, including test strips and analytical systems. Dr. Ranc’s interdisciplinary approach combines analytical method development, data analysis using Python, R, and Matlab, and project management of EU-funded research. His current Horizon Europe projects focus on medical applications of nanotechnology, contributing to improved diagnostics, drug delivery systems, and authenticity verification. Through collaborations with European research institutions and industries, Dr. Ranc is pushing the boundaries of next-gen biomedical and analytical technologies.

Publication Top Notes:

  1. Magnetic 2D Transition-Metal-Based Nanomaterials in Biomedicine: Opportunities and Challenges in Cancer Therapy

  2. Highly Cytotoxic Copper(II) Mixed-Ligand Quinolinonato Complexes: Pharmacokinetic Properties and Interactions with Drug Metabolizing Cytochromes P450

  3. Graphene Oxide Nanoplatforms to Enhance Cisplatin-Based Drug Delivery in Anticancer Therapy

  4. Polymer-Based Graphene Derivatives and Microwave-Assisted Silver Nanoparticles Decoration as a Potential Antibacterial Agent

  5. New Limits for Stability of Supercapacitor Electrode Material Based on Graphene Derivative

  6. Label-free Determination of Prostate Specific Membrane Antigen in Human Whole Blood by Magnetically Assisted SERS

  7. Cyanographene and Graphene Acid: Emerging Derivatives Enabling High-Yield and Selective Functionalization of Graphene

  8. Detection of Prosthetic Joint Infection Based on Magnetically Assisted Surface Enhanced Raman Spectroscopy

  9. Functional Nanosheet Synthons by Covalent Modification of Transition-Metal Dichalcogenides

  10.  Nanoporous Nitrogen-Doped Graphene Oxide/Nickel Sulfide Composite Sheets for Hydrogen and Oxygen Evolution

Conclusion:

In conclusion, Dr. Václav Ranc is an exceptional candidate for the Best Researcher Award, demonstrating a rare synergy of academic excellence, applied innovation, and impactful leadership. His contributions to analytical chemistry and nanotechnology have advanced both scientific understanding and practical diagnostic solutions. His impressive publication record, international collaborations, patent portfolio, and success in leading multimillion-euro projects set him apart as a researcher of outstanding merit. With minor expansion into global research programs and commercialization efforts, Dr. Ranc is poised to further amplify his already significant impact. For his sustained contributions to science, his ability to lead and innovate, and his commitment to solving real-world problems through chemistry and nanotechnology, Dr. Václav Ranc is highly deserving of the Best Researcher Award.

Chang Feng | Cancer Cell Biology | Best Researcher Award

Dr. Chang Feng | Cancer Cell Biology | Best Researcher Award

Dr. Chang Feng , Shanghai University , China

Chang Feng is a distinguished researcher in the fields of tumor molecular diagnosis, biosensing, and intelligent DNA. Born in Shanghai, China, on January 1, 1988, Chang Feng pursued a rigorous academic journey, completing his Ph.D. at Nanjing University (2015-2019) after earning his M.D. from Shanghai University (2012-2015). He is currently a lecturer at Shanghai University since 2019. Feng has contributed significantly to scientific advancements in cancer diagnostics, molecular biosensors, and cutting-edge DNA research. His works often involve the development of innovative detection techniques and the creation of novel DNA-based diagnostic systems. Feng has a collaborative approach, working with multiple researchers to achieve groundbreaking results. His publications in prestigious journals highlight his expertise in developing biosensors, RNA origami, and catalytic DNAzymes for biomedical applications.

Publication Profile: 

Scopus

Strengths for the Award:

Chang Feng’s research is exceptional and well-suited for the Best Researcher Award. His expertise spans across tumor molecular diagnosis, biosensor development, and intelligent DNA systems. His contributions to cancer diagnostics, bioimaging, and biosensing technologies are groundbreaking. Feng has published several high-impact articles in leading journals, demonstrating significant advancements in DNAzymes, electrochemical biosensing, and RNA origami. His work in designing innovative DNA-based diagnostic platforms and cancer therapies reflects his ability to integrate chemistry, biology, and engineering, providing novel solutions for clinical applications. Feng’s interdisciplinary approach and leadership in the field have earned him numerous collaborations with researchers and institutions globally, further enhancing his credibility as a top-tier researcher.

Areas for Improvements:

While Feng has made remarkable contributions to scientific research, one area for improvement is expanding his focus to more clinical applications of his findings. Commercializing his biosensing technologies for real-world healthcare implementation would increase the practical impact of his work. Additionally, improving outreach through public science communication could help raise awareness of his advancements and engage a broader audience.

Education:

Chang Feng received his M.D. from Shanghai University in 2015, where he developed a strong foundation in molecular biology, diagnostics, and bioengineering. His doctoral journey continued at Nanjing University (2015-2019), where he obtained his Ph.D. focusing on tumor molecular diagnosis and biosensing technologies. During his time at Nanjing University, Feng’s research concentrated on the development of DNA-based biosensors and new methodologies for cancer detection. His education at these esteemed institutions provided him with the technical expertise necessary to pioneer groundbreaking research in the field of molecular diagnostics. Feng’s academic training involved rigorous coursework in molecular biology, chemical engineering, and bioinformatics, contributing significantly to his current work in bioimaging, biosensing, and the development of intelligent DNA systems.

Experience:

Chang Feng has a strong academic and research career, currently serving as a lecturer at Shanghai University since 2019. Prior to his current role, he earned his Ph.D. at Nanjing University (2015-2019) and M.D. from Shanghai University (2012-2015). Throughout his career, Feng has collaborated with leading researchers, contributing to the development of innovative biosensing technologies and cancer diagnostics. His work includes advancing DNA-based biosensors, DNAzyme probes, and other cutting-edge diagnostic tools. As a lecturer, Feng mentors graduate students and participates in academic teaching and research projects. He has been involved in several collaborative publications that have furthered the field of molecular biosensors, focusing on intelligent DNA-based systems and tumor detection methodologies. Feng’s research experience combines theoretical knowledge with practical applications, making him a recognized figure in the field of biosensor research and molecular diagnostics.

Research Focus:

Chang Feng’s primary research focus lies in tumor molecular diagnosis, biosensor development, and intelligent DNA systems. He is particularly interested in advancing technologies for cancer detection through the application of molecular biosensors, bioimaging, and intelligent DNA devices. His research explores the use of DNAzymes, catalytic DNA molecules, and RNA origami for targeted molecular detection, with a focus on enhancing the sensitivity and specificity of cancer diagnostics. Feng’s work also investigates the use of biosensors for the detection of small molecules, leveraging innovative electrochemical and fluorescence-based platforms. His interdisciplinary approach combines elements of chemistry, biology, and engineering to create advanced diagnostic systems with potential clinical applications. Feng is dedicated to improving the efficiency of diagnostic tools and is committed to developing more accurate and faster methods for early cancer detection and molecular analysis.

Publications Top Notes:

  1. Single-cell analysis of highly metastatic circulating tumor cells by combining a self-folding induced release reaction with a cell capture microchip 🧬🔬 (Anal. Chem., 2021)
  2. Hierarchical biomarkers detection via a universal polydopamine probe catalyzed by a hexagonal star-nanostructured DNAzyme 🔬🧪 (Sensor. Actuat. B-Chem., 2022)
  3. Construction of a ternary complex based DNA logic nanomachine for a highly accurate imaging analysis of cancer cells 🧬💡 (ACS Sens., 2020)
  4. Lantern-shaped flexible RNA origami for Smad4 mRNA delivery and growth suppression of colorectal cancer 🧬🦠 (Nat. Commun., 2023)
  5. Liquid-colloid-solid modular assembly for three-dimensional electrochemical biosensing of small molecules 💧⚡ (Biosens. Bioelectron., 2024)
  6. Dual-targets binding protection mediated rolling circle transcription with tandem fluorescent RNA aptamers for label-free detection of liver cancer biomarkers 🧬🦠 (Sensor. Actuat. B-Chem., 2024)
  7. Cell-Free Biosensing Genetic Circuit Coupled with Ribozyme Cleavage Reaction for Rapid and Sensitive Detection of Small Molecules 🧬⚡ (ACS Synth. Biol., 2023)
  8. A portable and partitioned DNA hydrogel chip for multitarget detection 💧🧬 (Lab Chip., 2023)

Conclusion:

Chang Feng’s research in tumor molecular diagnostics, biosensors, and intelligent DNA is truly cutting-edge. His scientific rigor, collaboration with top researchers, and groundbreaking discoveries in cancer detection and biosensing technologies make him a deserving candidate for the Best Researcher Award. By continuing to bridge the gap between laboratory research and clinical applications, Feng will likely have an even greater impact in advancing medical diagnostics and therapeutic strategies.

Sanjay Kumar | Cancer Cell Biology | Best Researcher Award

Dr. Sanjay Kumar | Cancer Cell Biology | Best Researcher Award

Dr. Sanjay Kumar , Tohoku University , Japan

Dr. Sanjay Kumar is an Assistant Professor at the Institute of Multidisciplinary Research for Advanced Materials (IMRAM), Tohoku University, Japan. With expertise in natural products chemistry, he has made significant contributions in the field of anti-infective compounds, nanoparticle-based drug delivery, and environmental remediation. His multidisciplinary research spans across pharmaceuticals, biotechnology, and environmental sciences. Dr. Kumar holds a Ph.D. in Natural Products Chemistry from NIPER, India. He is proficient in Hindi, English, Punjabi, and Japanese, facilitating collaborations across diverse global platforms. Apart from his academic role, he has been a JSPS Postdoctoral Researcher at Tohoku University. His passion for innovation has earned him recognition in both national and international academic communities. He actively participates in fostering advanced scientific discussions and technological advancements, helping shape the future of health and environmental science.

Publication Profile:

Orcid

Strengths for the Award:

  1. Extensive Research Experience: Dr. Kumar’s career spans multiple prestigious institutions, particularly his current position as an Assistant Professor at Tohoku University in Japan. His journey from postdoctoral roles to faculty positions reflects his deepening expertise and commitment to advancing research.
  2. Diverse Research Contributions: His publications cover a wide range of topics in natural products chemistry, microbial endophytes, pharmaceutical applications, and drug discovery. He has contributed significantly to the fields of anti-infective compounds, antimicrobial activity, cancer therapy, and environmental science (e.g., microbial remediation for wastewater treatment). This diversity in research themes highlights his ability to address multifaceted scientific problems.
  3. Collaborative Work: Dr. Kumar’s collaborative approach is demonstrated by his co-authorship on numerous high-quality research papers and book chapters with prominent scientists. This speaks to his ability to work effectively in multidisciplinary teams and contribute to impactful research.
  4. Leadership and Impact: As an Assistant Professor, Dr. Kumar has shown leadership in mentoring students and researchers, as well as contributing to major international research projects. His involvement in both basic and applied research, such as drug delivery systems, biotechnological aspects of nanoparticles, and biochemical processes in plants, indicates a deep understanding of scientific applications with real-world relevance.
  5. Awards and Recognition: His work has been published in high-impact journals like Nanoscale, Medicinal Chemistry, and MRS Communications. This not only enhances his visibility within the scientific community but also reflects the importance and quality of his research.

Areas for Improvement:

  1. Increased Public Engagement: Although Dr. Kumar has an impressive academic record, increasing his presence in public science communication could broaden the impact of his research. For example, contributing to public talks, outreach programs, or media could further elevate his work’s accessibility to a broader audience.
  2. International Collaborations: While Dr. Kumar has significant collaborations in Japan and India, expanding his research partnerships globally (e.g., with research centers in Europe, North America, etc.) could increase the visibility of his work and open doors for cross-continental innovation.
  3. Grant Proposals and Funding: A focus on securing larger, international research grants could accelerate Dr. Kumar’s research, especially for high-cost projects involving experimental trials and advanced technologies.

Education:

Dr. Sanjay Kumar completed his Ph.D. in Natural Products Chemistry at NIPER, S.A.S. Nagar, Punjab, India (2014-2018), where he deepened his expertise in bioactive compounds and pharmaceutical applications. Prior to that, he earned an M.S. in Pharm. (Natural Products Chemistry) from the same institution (2011-2013). His foundational education was a Bachelor of Pharmacy (B. Pharmacy) from SHUATS, Allahabad, U.P, India (2007-2011). During his academic journey, Dr. Kumar also pursued training courses, including ISO/IEC 17025:2017 certification at Green Economy Initiatives Pvt. Ltd. and a Diploma in Computer Applications. Additionally, he attended a General Course on Intellectual Property from WIPO Worldwide Academy, Switzerland (2010). These qualifications have allowed him to gain a diverse skill set, blending scientific knowledge with practical industry insights, which he applies in his research endeavors.

Experience:

Dr. Sanjay Kumar has an extensive academic and research background, contributing to several prestigious institutions. Currently, he serves as an Assistant Professor at the Institute of Multidisciplinary Research for Advanced Materials (IMRAM), Tohoku University, Japan, where he also conducted postdoctoral research (2020-2024). His previous role as a JSPS Postdoctoral Researcher at Tohoku University (2022-2024) further enhanced his expertise. Before that, Dr. Kumar worked as a Project Scientist at Punjab Biotechnology Incubator (PBTI), Mohali, India (2018-2020), where he applied his knowledge in the pharmaceutical and biotechnology sectors. His academic career began as a Junior Research Fellow (JRF) at NIPER, India (2014), followed by a brief tenure as Assistant Professor at SIPSAR, Greater Noida (2013-2014). His research focuses on interdisciplinary topics, with a particular emphasis on pharmaceuticals, natural products, and environmental sciences, reflecting his diverse and multi-faceted experience.

Awards and Honors:

Dr. Sanjay Kumar has earned several accolades in recognition of his pioneering work in scientific research. His remarkable contributions to anti-infective compounds and natural product-based drug design have garnered international attention. As an active researcher, he has received the prestigious JSPS Postdoctoral Fellowship at Tohoku University, Japan, which is highly competitive and recognizes excellence in the scientific community. His work on bioactive metabolites, drug delivery, and microbial remediation has been featured in renowned academic journals and international conferences. Additionally, he was honored for his contributions to biotechnology during his tenure at the Punjab Biotechnology Incubator. Dr. Kumar’s research has also contributed significantly to the field of environmental science, particularly in areas of xenobiotic degradation and wastewater treatment. His continued success and recognition reflect his commitment to advancing scientific knowledge and contributing to solving global challenges.

Research Focus:

Dr. Sanjay Kumar’s research is primarily focused on the intersection of natural products chemistry, pharmacology, and environmental science. His work involves exploring bioactive compounds from natural sources, with a particular focus on anti-infective and antimicrobial agents produced by endophytic fungi. He is dedicated to discovering novel drug delivery systems using nanoparticles and other advanced materials for targeted therapies, especially in minimally invasive cancer treatments. In addition, his research extends to microbial remediation strategies, including wastewater treatment and xenobiotic degradation. Dr. Kumar’s projects also delve into the biochemical processes affected by arsenic in plants, as well as the synthesis of pharmaceutical compounds with potential antimicrobial and anti-malarial properties. He is interested in understanding how natural products can address global health challenges, particularly in the face of increasing antibiotic resistance. His research aims to create solutions that integrate pharmaceuticals with environmental sustainability.

Publication Top Notes:

  1. “Recent Advances in Anti-Infective Compounds Produced by Endophytic Fungi” 📚
  2. “Arsenic‐Induced Responses in Plants: Impacts on Biochemical Processes” 📘
  3. “Pathogenesis and Antibiotic Resistance of Staphylococcus aureus” 🦠
  4. “Endophytic Microbes in Abiotic Stress Management” 🌱
  5. “Endophytic Bacteria in Xenobiotic Degradation” 🧬
  6. “Microbial Remediation for Wastewater Treatment” 💧
  7. “Current Trends in Mycobacterium tuberculosis Pathogenesis and Drug Resistance” 🦠
  8. “Carrier-Free Nano-Prodrugs for Minimally Invasive Cancer Therapy” 💊
  9. “Photodynamic Antimicrobial Activity of Polydiacetylene Crystal Nanostructure Against E. coli” 🦠
  10. “A Concise Synthesis of Methyl Dihydrojasmonate and Methyl (5-Methylidene-4-Oxocyclopent-2-En-1-Yl)Acetate from D-Glucose” 🧪

Conclusion:

Dr. Sanjay Kumar’s exceptional research contributions in natural products chemistry, antimicrobial resistance, biotechnology, and nanotechnology position him as a strong candidate for the Best Researcher Award. His consistent dedication to groundbreaking, multidisciplinary research and his leadership within the scientific community make him an outstanding contender. With minor improvements in expanding global collaborations and public outreach, Dr. Kumar could further elevate his profile as a leading researcher.